Evidence map›Paper›PMID 29634390›Full record

ArticleAutophagy2018

Crosstalk between lysine methylation and phosphorylation of ATG16L1 dictates the apoptosis of hypoxia/reoxygenation-induced cardiomyocytes.

Huiwen Song, Xing Feng, Min Zhang, Xian Jin, Xiangdong Xu, Lin Wang, Xue Ding, Yunmei Luo, Fengqin Lin, Qin Wu and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Histone demethylases in autophagy and inflammation.Cell communication and signaling : CCS · 2025
    Review
  8. ZDHHC7-mediatedAutophagy · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 4 countries.

Huiwen Songa Department of Cardiology , Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences ; Shanghai , China.
Xing Fengb Longju Medical Research Center ; Key Laboratory of Basic Pharmacology of Ministry of Education ; Zunyi Medical University ; Zunyi , China.ORCID 0000-0001-8226-3389
Min Zhangd Laboratory of Cardiovascular Immunology; Key Laboratory of Biological Targeted Therapy of the Ministry of Education; Institute of Cardiology; Union Hospital; Tongji Medical College of Huazhong University of Science and Technology ; Wuhan , China.
Xian Jine Department of Cardiology ; Minhang Hospital ; Fudan University ; Shanghai , China.
Xiangdong Xua Department of Cardiology , Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences ; Shanghai , China.
Lin Wangf Department of Cardiology ; Tongji Hospital ; Tongji Medical College ; Huazhong University of Science and Technology ; Wuhan , China.
Xue Dingg Department of Cardiology ; the First Affiliated Hospital ; Harbin Medical University ; Harbin , China.
Yunmei Luob Longju Medical Research Center ; Key Laboratory of Basic Pharmacology of Ministry of Education ; Zunyi Medical University ; Zunyi , China.
Fengqin Linb Longju Medical Research Center ; Key Laboratory of Basic Pharmacology of Ministry of Education ; Zunyi Medical University ; Zunyi , China.
Qin Wuh Key Laboratory of Basic Pharmacology of Ministry of Education ; Zunyi Medical University ; Zunyi , China.
Guiyou Liangi Department of Cardiovascular Surgery ; Affiliated Hospital of Zunyi Medical University ; Zunyi , China.
Tian Yuj Department of Anesthesia ; Affiliated Hospital of Zunyi Medical University ; Zunyi , China.
Qigong Liuf Department of Cardiology ; Tongji Hospital ; Tongji Medical College ; Huazhong University of Science and Technology ; Wuhan , China.
Zhiyong Zhangb Longju Medical Research Center ; Key Laboratory of Basic Pharmacology of Ministry of Education ; Zunyi Medical University ; Zunyi , China.ORCID 0000-0001-8576-1607
Zunyi Medical University · CNRutgers, The State University of New Jersey · USTongji Hospital · CNFudan University · CNHarbin Medical University · CNJiading District Central Hospital · CNLaboratory of Molecular Genetics · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Post-translational modifications of autophagy-related (ATG) genes are necessary to modulate their functions. However, ATG protein methylation and its physiological role have not yet been elucidated. The methylation of non-histone proteins by SETD7, a SET domain-containing lysine methyltransferase, is a novel regulatory mechanism to control cell protein function in response to various cellular stresses. Here we present evidence that the precise activity of ATG16L1 protein in hypoxia/reoxygenation (H/R)-treated cardiomyocytes is regulated by a balanced methylation and phosphorylation switch. We first show that H/R promotes autophagy and decreases SETD7 expression, whereas autophagy inhibition by 3-MA increases SETD7 level in cardiomyocytes, implying a tight correlation between autophagy and SETD7. Then we demonstrate that SETD7 methylates ATG16L1 at lysine 151 while KDM1A/LSD1 (lysine demethylase 1A) removes this methyl mark. Furthermore, we validate that this methylation at lysine 151 impairs the binding of ATG16L1 to the ATG12-ATG5 conjugate, leading to inhibition of autophagy and increased apoptosis in H/R-treated cardiomyocytes. However, the cardiomyocytes with shRNA-knocked down SETD7 or inhibition of SETD7 activity by a small molecule chemical, display increased autophagy and decreased apoptosis following H/R treatment. Additionally, methylation at lysine 151 inhibits phosphorylation of ATG16L1 at S139 by CSNK2 which was previously shown to be critical for autophagy maintenance, and vice versa. Together, our findings define a novel modification of ATG16L1 and highlight the importance of an ATG16L1 phosphorylation-methylation switch in determining the fate of H/R-treated cardiomyocytes.

Indexed as

ApoptosisAmino Acid SequenceAnimalsAutophagyAutophagy-Related ProteinsCarrier ProteinsCell HypoxiaHEK293 CellsHistone DemethylasesHistone-Lysine N-MethyltransferaseHumansLysineMethylationMiceMyocytes, CardiacOxygenATG16L1 protein, humanAtg16l1 protein, mouseAtg16L1 protein, ratAutophagy-Related ProteinsCarrier ProteinsHistone DemethylasesHistone-Lysine N-MethyltransferaseKDM1A protein, humanLysineOxygenProtein MethyltransferasesSetd7 protein, mouseVesicular Transport ProteinsATG16L1cardiomyocyteCSNK2KDM1A/LSD1SETD7

Identifiers

PMID29634390
PMCPMC6070011
OpenAlexW2797083856

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.